Cargando…
Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report
EGFR tyrosine kinase inhibitors (EGFR-TKIs) have revolutionized the treatment of non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, targeted therapies impose a strong selective pressure against the coexisting tumor populations that lead to the emergence of resistant...
Autores principales: | Simarro, Javier, Pérez-Simó, Gema, Mancheño, Nuria, Muñoz-Núñez, Carlos Francisco, Cases, Enrique, Juan, Óscar, Palanca, Sarai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141594/ https://www.ncbi.nlm.nih.gov/pubmed/35626421 http://dx.doi.org/10.3390/diagnostics12051266 |
Ejemplares similares
-
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital
por: Simarro, Javier, et al.
Publicado: (2023) -
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
por: Simarro, Javier, et al.
Publicado: (2022) -
Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital
por: Simarro, Javier, et al.
Publicado: (2019) -
MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase
por: Tarazón, Estefanía, et al.
Publicado: (2021) -
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia
por: Gil, José Vicente, et al.
Publicado: (2023)